HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Eprinomectin B1a

HCID 6444397
NotesReactions
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
133305-88-1
Standard SMILES
CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@H](NC(C)=O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2
InChIKey
ZKWQQXZUCOBISE-CRTGXIDZSA-N
Molecular formula
C50H75NO14
Average molar mass
914.1 g/mol
Monoisotopic mass
913.51875607

Names & identifiers

Preferred name
Eprinomectin B1a
IUPAC
N-[(2S,3R,4S,6S)-6-[(2S,3S,4S,6R)-6-[(1'R,2R,3S,4'S,6S,8'R,10'E,12'S,13'S,14'E,16'E,20'R,21'R,24'S)-2-[(2S)-butan-2-yl]-21',24'-dihydroxy-3,11',13',22'-tetramethyl-2'-oxospiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-12'-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-4-methoxy-2-methyloxan-3-yl]acetamide
English name
EprinoMectin B1a
Molecular formula
C50H75NO14
Molecular weight
914.14

Names & synonyms

Eprinomectin component B1aEprinomectin B1a133305-88-1Eprinomectin component B1UNII-00OY54D31C(4''R)-4''-(Acetylamino)-5-O-demethyl-4''-deoxyavermectin A1a00OY54D31CEPRINOMECTIN COMPONENT B1A [MI]AVERMECTIN A1A, 4 SUP(2)-(ACETYLAMINO)-5-O-DEMETHYL-4 SUP(2)-DEOXY-, (4 SUP(2)R)-DTXCID0028903CHEBI:82597RefChem:137403
Show more names
Eprinomectin Component BPhenyl Acetate Impurity 14ZKWQQXZUCOBISE-NAMFGXNGSA-N
4''-(acetylamino)-5-O-demethyl-4''-deoxy-, (4''R)-Avermectin A1a(2aE,4E,5'S,6S,6'R,7S,8E,11R,13S,15S,17aR,20R,20aR,20bS)-6'-((2S)-butan-2-yl)-20,20b-dihydroxy-5',6,8,19-tetramethyl-17-oxo-5',6,6',10,11,14,15,17,17a,20,20a,20b-dodecahydro-2H,7H-spiro(11,15-methanofuro(4,3,2-pq)(2,6)benzodioxacyclooctadecin-13,2'-pyran)-7-yl 4-O-(4-acetamido-2,4,6-trideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranoside(2aE,4E,5'S,6S,6'R,7S,8E,11R,13S,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17-oxo-5',6,6',10,11,14,15,17,17a,20,20a,20b-dodecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2'-pyran]-7-yl 4-O-(4-acetamido-2,4,6-trideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosideDTXSID0048977ZKWQQXZUCOBISE-RRWHDBBXSA-NAKOS040758829Avermectin A1a, 4''-(acetylamino)-5-O-demethyl-4''-deoxy-, (4''R)-C50H75NO14

Properties

Computed structural properties

XLogP
3.8
Topological polar surface area
179 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
14
Rotatable bonds
9
Heavy atoms
65
Formal charge
0
Complexity
1,850

Experimental & physicochemical properties

Collision Cross Section304.03 Ų [M-H]-

Physicochemical properties

Boiling point
992.6 · 992.6±65.0 °C(Predicted)
Density
1.23 · 1.23±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
DMF: soluble; DMSO: soluble; Ethanol: soluble; Methanol: soluble
form
A solid
pka
12.42 · 12.42±0.70(Predicted)
FDA UNII
0 OY54D31C · 00OY54D31C
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
319 · H319-H315
Precautionary statements
264 · P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H319-H315
Precautionary statements
P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362

Chemistry & industry

Applications · 1 item

UsesEprinomectin B1a is a semi-synthetic analogue of avermectin B1a prepared by oxidation of the 4”-hydroxy moiety and reductive amination followed by acetylation. Eprinomectin B1a is the major component (>90%) of the commercial product for endo- and exo-parasite control, eprinomectin. Members of the avermectin/milbemycin class exert their anthelmintic effects by binding to glutamate-gated chloride channels expressed on nematode neurones and pharyngeal muscle cells. The avermectins and milbemycins are also potent insecticides and acaricides.

Suppliers21 total

湖北瑞玛标物科技有限公司15787879035 15787875101 · [email protected]
上海赛可锐生物科技有限公司021-58000709 13120558703 · [email protected]
孟成科技(上海)有限公司400-820-6829 · [email protected]
上海维亦特生物科技有限公司15317051735 · [email protected]
Shanghai Scibiotron Pharmaceutical Co., Ltd+86-16621589600 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
台州川旭医药科技有限公司[email protected] 15165038510 · [email protected]
厦门志信化学有限公司+86-5922680277 +86-13806087780 · [email protected]
西安莱茵生物科技有限公司86-(0)29-85992781 17792393971 · [email protected]
Novachemistry

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
133305-88-1
PubChem CID
6444397
DTXSID
DTXSID001369445
UNII
00OY54D31C
EC Number
687-666-1
44-20819178-90 02081917890 · [email protected]
上海宏叶生物科技有限公司400-9205774 400-920-5774 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
常州翔龙医药科技有限公司18661161657 · [email protected]
TLC梯尔希(南京)药物研发有限公司18012923235 18012923235 · [email protected]
BOC Sciences+1-631-485-4226 · [email protected]
ChemeGen 中国18818260767 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
DAYANG CHEM (HANGZHOU) CO.,LTD+86-88938639 +86-17705817739 · [email protected]
TargetMol中国(陶术生物)15002134094 · [email protected]
北京艾普瑞特科技有限公司13311015623 · [email protected]
南京世洲生物科技有限公司025-85560043 15850508050 · [email protected]
Additional notes · 1 item

DefinitionChEBI: An avermectin analogue that is avermectin A1a in which the methoxy group attached to the tetrahydrobenzofuranyl moiety is replaced by a hydroxy group and in which the hydroxy group at position 4 of the terminal 2,6-dideoxy-3-O /element>-methyl-alpha-L-arabino-hyxopoyranosyl group is replaced by an acetamido group.